China Foods Holdings Ltd. CFOO

FY2025 · ended Dec 31, 2025 · Revenue $327,871, +40.5% YoY · Filed Apr 16, 2026

China Foods Holdings Ltd. (CFOO) files with the SEC under industry code 2833, Medicinal Chemicals & Botanical Products. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $327,871 and a net loss of $398,672. As of Jun 30, 2026 it held $15,923 in cash and investments and $15,479 in total debt.

Revenue (TTM)
$185,871
-46.6% vs year-ago TTM
Net income (TTM)
$-323,112
+33.6% vs year-ago TTM
Operating cash flow (TTM)
$-352,343
+17.0% vs year-ago TTM
Free cash flow
$-377,266
-18.8% vs prior year
EPS (TTM)
$-0.02
+33.6% vs year-ago TTM
Dividend per share
None
Shares outstanding
20.25M
+0.0% vs prior year
Net cash
$444
as of Jun 30, 2026
Operating margin
-173.9%
FY 2026

Company profile

Industry
Medicinal Chemicals & Botanical Products (SIC 2833)
Listed as
CFOO (OTC)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Wanchai, Hong Kong
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1310630
Former names
Trafalgar Resources, Inc. (until Feb 20, 2019)

Other Medicinal Chemicals & Botanical Products companies

Key figures

Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.

Line
FY 2025
Dec 31, 2025
FY 2024
Dec 31, 2024
FY 2023
Dec 31, 2023
FY 2022
Dec 31, 2022
FY 2021
Dec 31, 2021
Revenue
$327,871
$233,339
$158,475
$354,096
$361,116
Operating income
-$398,923
-$455,637
-$404,637
-$392,733
-$456,430
Net income
-$398,672
-$455,571
-$403,700
-$354,078
-$455,409
Diluted EPS
-$0.02
-$0.02
-$0.02
—
—
Operating cash flow
-$389,251
-$353,812
-$316,916
-$171,598
-$438,620
Free cash flow
—
-$377,266
-$317,662
—
-$465,978
Total assets
$212,890
$435,005
$365,181
$679,208
$1.6M
Total liabilities
$1.5M
—
—
—
—
Stockholders' equity
-$1.3M
-$850,807
-$390,815
$17,429
$400,701
Cash and investments
$9,893
$39,192
$174,877
$381,709
$609,434
Total debt
$20,424
—
$21,038
$20,341
$360,154

Recent SEC filings

Recent SEC filings
Form Description Filed Period
10-Q Quarterly report Aug 14, 2026 Jun 30, 2026
10-Q Quarterly report May 15, 2026 Mar 31, 2026
10-K Annual report Apr 16, 2026 Dec 31, 2025
8-K Current report
Auditor change
Mar 30, 2026 Mar 5, 2026
10-Q Quarterly report Nov 14, 2025 Sep 30, 2025
10-Q Quarterly report Aug 14, 2025 Jun 30, 2025

Source: SEC EDGAR filings. This is company-reported data, not investment advice.